BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Durchschein F, Eherer A, Grill M, Sturm EM, Pommer V, Langner C, Högenauer C, Schicho R. Involvement of EP2 and EP4 Receptors in Eosinophilic Esophagitis: A Pilot Study. Dig Dis Sci 2019;64:2806-14. [PMID: 30989466 DOI: 10.1007/s10620-019-05623-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 van Geffen C, Deißler A, Beer-Hammer S, Nürnberg B, Handgretinger R, Renz H, Hartl D, Kolahian S. Myeloid-Derived Suppressor Cells Dampen Airway Inflammation Through Prostaglandin E2 Receptor 4. Front Immunol 2021;12:695933. [PMID: 34322123 DOI: 10.3389/fimmu.2021.695933] [Reference Citation Analysis]
2 Oliva S, Azouz NP, Stronati L, Rothenberg ME. Recent advances in potential targets for eosinophilic esophagitis treatments. Expert Rev Clin Immunol 2020;16:421-8. [PMID: 32163308 DOI: 10.1080/1744666X.2020.1742110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Knuplez E, Sturm EM, Marsche G. Emerging Role of Phospholipase-Derived Cleavage Products in Regulating Eosinophil Activity: Focus on Lysophospholipids, Polyunsaturated Fatty Acids and Eicosanoids. Int J Mol Sci 2021;22:4356. [PMID: 33919453 DOI: 10.3390/ijms22094356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]